glp-1 vs glp-3 vs. GLP-1 + GIP: What's the Difference for your Metabolism? Lilly orforglipron oral GLP-1 phase
Description
A few GLP-1 agonists currently in phase 3 trials are higher-dose injectable semaglutide 7.2 mg (Novo Nordisk), oral semaglutide 50 mg (Novo Nordisk) and orforglipron (Eli Lilly)
"Failure" can mean inadequate weight loss, intolerable side effects, or documented contraindications
Available at: Health.com
Reply N Engl J Med
Yeit OO, Sarbeyliler G, Karada P, et al
